Indication. The term “
Indication. BA058 is indicated for the treatment of postmenopausal women with osteoporosis who are at high risk of fracture. BA058 is indicated to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk of fracture. Efficacy: Statistically equivalent or superior effect on BMD relative to Forteo®. Dosing: Significantly shortened dosing cycle to restore BMD (vs. 12+ months for Forteo®) when administered QD via subcutaneous administration. Alternatively, significantly shortened dosing schedule than once-daily (e.g. 3 times/week). Improved formulations that allow a significant advance in dosing convenience along with reduced pain. Safety: Absence of significant hypercalcemia with BA058 treatment.
Indication. (including preferences) of the academic center(s) (including online) at which the faculty member is interested in teaching.
Indication. If the content of this policy differs from the insurance request or the agreed clauses, the Policyholder may request that the Company rectifies the error within one month, starting from the date the policy is signed. If this period elapses without the Policyholder making such a request, the provisions of the policy will be followed. Supplementary insurance for civil liability Definitions: Insured amount: The amounts established in the Specific and General Terms and Conditions, the maximum limit of compensation to be paid by the Insurance Company in the event of an accident.
Indication. Recent NICE guidance (NICE NG 87 March 2018) now advocates that medication can be considered for children aged 5 years and above. Prior to this, 6 years old was the recommendation and hence this makes prescribing in 5 year olds unlicensed but is supported by NICE if deemed clinically appropriate. Methylphenidate, dexamfetamine, and lisdexamfetamine are stimulant drugs used in the treatment of severe Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Disorder (ADD) and Hyperkinetic Disorder (HKD) as part of a comprehensive treatment approach when remedial measures alone prove insufficient. Methylphenidate is licensed in children of 6 years old and over. Lisdexamfetamine is licensed in children aged 6 years of age and over when response to previous methylphenidate treatment is considered clinically inadequate. Dexamfetamine is licensed for the treatment of refractory ADHD in children over 3 years.
Indication. As used herein, “Indication” means the intended use of a Licensed Product for either therapeutic treatment or for the prevention of a distinct illness, sickness, interruption, cessation or disorder of a particular bodily function, system, tissue type or organ, or sign or symptom of any such items or conditions, regardless of the severity, frequency or route of any treatment, treatment regimen, dosage strength or patient class, for which Regulatory Approval is being sought and which will be referenced on any Licensed Product labeling in any country. Label extensions shall not be deemed to be separate Indications. By way of example, each of the following would be considered a separate Indication: breast cancer, prostate cancer, colon cancer, gastric cancer, lung cancer, etc.
Indication. ACBS indications for Oral Nutritional Supplements (ONS) apply and must be clearly documented within the patient’s dietetic record of care and on any other relevant paperwork e.g. ONS product request forms / letters. ACBS indications vary for different products, therefore it is sensible to consult the English Drug Tariff which has a definitive list of ACBS indications and specifies these for each ONS product: English Drug Tariff There is a list of standard indications which apply to some ONS products: Short bowel syndrome Intractable malabsorption Pre-operative preparation of patients who are undernourished Proven inflammatory bowel disease Following total gastrectomy Dysphagia, bowel fistulae or Disease related malnutrition However it is important to note than many commonly used ONS do not have standard ACBS indications. People who do not meet the ACBS criteria should be advised about suitable food fortification and the option of purchasing suitable over the counter ONS. The NHSGGC Clinical Guideline: ONS Prescribing in Adults (oral use): Six stage approach provides guidance for all health and social care staff involved in ONS prescribing, use and monitoring across all settings.
Indication. (including preferences) of courses that the faculty member is interested in teaching and believes he/she is qualified to teach.
Indication. In further consideration of the license rights granted to Company under Section 2.1, Company shall promptly provide written notification to Xxxxxxx, at Beerse (Belgium), Xxxxxxxxxxxxx 00, Xxxxxxxxx: Finance Manager ([…***…]) upon achievement of each Development Milestone. Such notification shall indicate that the Development Milestone was achieved and request that Xxxxxxx send a written invoice for such milestone to a specific address, if such address is different than that indicated in Section 15.11: Notices. Within […***…] days of the receipt of the invoice for each of the corresponding Development Milestones listed below, Company shall pay by wire transfer the amount listed in each invoice to Xxxxxxx to the bank account identified in Section 7.2. Development Milestone Event Milestone Payment (USD) (i) […***…] $ […***…] (ii) […***…] $ […***…] (iii) […***…] $ […***…] (iv) […***…] $ […***…]
Indication. The term “Indication” shall mean, with respect to a country, the labelled use of a Product for either therapeutic (including prophylactic) treatment or for the prevention of a distinct illness, sickness, interruption, cessation or disorder of a particular bodily function, system, tissue type or organ, or sign or symptom of any such items or conditions, regardless of the severity, frequency or route of any treatment, treatment regimen, dosage strength or patient class, for which Regulatory Approval has been obtained or is being sought in such country.
